147 related articles for article (PubMed ID: 29635165)
1. Discovery of 6-chloro-2-(propylthio)-8,9-dihydro-7H-purines containing a carboxamide moiety as potential selective anti-lung cancer agents.
Zhao TQ; Zhao YD; Liu XY; Wang B; Li ZH; He ZX; Zhang XH; Liang JJ; Ma LY; Liu HM
Eur J Med Chem; 2018 May; 151():327-338. PubMed ID: 29635165
[TBL] [Abstract][Full Text] [Related]
2. Purine derivatives with heterocyclic moieties and related analogs as new antitumor agents.
Fernández-Sáez N; Rubio-Ruiz B; Campos JM; Unciti-Broceta A; Carrión MD; Camacho ME
Future Med Chem; 2019 Jan; 11(2):83-95. PubMed ID: 30644318
[TBL] [Abstract][Full Text] [Related]
3. Purines and triazolo[4,3-e]purines containing pyrazole moiety as potential anticancer and antioxidant agents.
Shaaban OG; Abd El Razik HA; A Shams El-Dine SE; Ashour FA; El-Tombary AA; Afifi OS; Abu-Serie MM
Future Med Chem; 2018 Jun; 10(12):1449-1464. PubMed ID: 29788781
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiproliferative activity of 6,7-disubstituted-4-phenoxyquinoline derivatives bearing the 2-oxo-4-chloro-1,2-dihydroquinoline-3-carboxamide moiety.
Tang Q; Zhai X; Tu Y; Wang P; Wang L; Wu C; Wang W; Xie H; Gong P; Zheng P
Bioorg Med Chem Lett; 2016 Apr; 26(7):1794-8. PubMed ID: 26944614
[TBL] [Abstract][Full Text] [Related]
5. Discovery of 9H-purins as potential tubulin polymerization inhibitors: Synthesis, biological evaluation and structure-activity relationships.
Zhou ZZ; Shi XD; Feng HF; Cheng YF; Wang HT; Xu JP
Eur J Med Chem; 2017 Sep; 138():1126-1134. PubMed ID: 28763647
[TBL] [Abstract][Full Text] [Related]
6. Anticancer activity and cDNA microarray studies of a (RS)-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl]-6-chloro-9H-purine, and an acyclic (RS)-O,N-acetalic 6-chloro-7H-purine.
Caba O; Díaz-Gavilán M; Rodríguez-Serrano F; Boulaiz H; Aránega A; Gallo MA; Marchal JA; Campos JM
Eur J Med Chem; 2011 Sep; 46(9):3802-9. PubMed ID: 21684047
[TBL] [Abstract][Full Text] [Related]
7. Anti-proliferative activity of 2,6-dichloro-9- or 7-(ethoxycarbonylmethyl)-9H- or 7H-purines against several human solid tumour cell lines.
Morales F; Ramírez A; Conejo-García A; Morata C; Marchal JA; Campos JM
Eur J Med Chem; 2014 Apr; 76():118-24. PubMed ID: 24583351
[TBL] [Abstract][Full Text] [Related]
8. Novel 3-(2,6,9-trisubstituted-9H-purine)-8-chalcone derivatives as potent anti-gastric cancer agents: Design, synthesis and structural optimization.
Zhao TQ; Zhao YD; Liu XY; Li ZH; Wang B; Zhang XH; Cao YQ; Ma LY; Liu HM
Eur J Med Chem; 2019 Jan; 161():493-505. PubMed ID: 30388465
[TBL] [Abstract][Full Text] [Related]
9. Structure-guided development of purine amide, hydroxamate, and amidoxime for the inhibition of non-small cell lung cancer.
Huang MR; Hsu YL; Lin TC; Cheng TJ; Li LW; Tseng YW; Chou YS; Liu JH; Pan SH; Fang JM; Wong CH
Eur J Med Chem; 2019 Nov; 181():111551. PubMed ID: 31376567
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anticancer activity of (RS)-9-(2,3-dihydro-1,4-benzoxaheteroin-2-ylmethyl)-9H-purines.
Conejo-García A; García-Rubiño ME; Marchal JA; Núñez MC; Ramírez A; Cimino S; García MÁ; Aránega A; Gallo MA; Campos JM
Eur J Med Chem; 2011 Sep; 46(9):3795-801. PubMed ID: 21645946
[TBL] [Abstract][Full Text] [Related]
11. Promising 2,6,9-Trisubstituted Purine Derivatives for Anticancer Compounds: Synthesis, 3D-QSAR, and Preliminary Biological Assays.
O Salas C; Zarate AM; Kryštof V; Mella J; Faundez M; Brea J; Loza MI; Brito I; Hendrychová D; Jorda R; Cabrera AR; Tapia RA; Espinosa-Bustos C
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31881717
[TBL] [Abstract][Full Text] [Related]
12. Small molecule purine and pseudopurine derivatives: synthesis, cytostatic evaluations and investigation of growth inhibitory effect in non-small cell lung cancer A549.
Bistrović A; Grbčić P; Harej A; Sedić M; Kraljević-Pavelić S; Koštrun S; Plavec J; Makuc D; Raić-Malić S
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):271-285. PubMed ID: 29271659
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel 4(1H)-quinolone derivatives as potential antiproliferative and apoptosis inducing agents.
Zhou P; Huang L; Zhou J; Jiang B; Zhao Y; Deng X; Zhao Q; Li F
Bioorg Med Chem Lett; 2017 Sep; 27(17):4185-4189. PubMed ID: 28757067
[TBL] [Abstract][Full Text] [Related]
14. Identification of thiazolo[5,4-d]pyrimidine derivatives as potent antiproliferative agents through the drug repurposing strategy.
Li ZH; Zhang J; Liu XQ; Geng PF; Ma JL; Wang B; Zhao TQ; Zhao B; Wei HM; Wang C; Fu DJ; Yu B; Liu HM
Eur J Med Chem; 2017 Jul; 135():204-212. PubMed ID: 28456031
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of new steroidal pyridines as potential anti-prostate cancer agents.
Shi YK; Wang B; Shi XL; Zhao YD; Yu B; Liu HM
Eur J Med Chem; 2018 Feb; 145():11-22. PubMed ID: 29310026
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anticancer activity of novel C6-piperazine substituted purine steroid-nucleosides analogues.
Huang LH; Xu HD; Yang ZY; Zheng YF; Liu HM
Steroids; 2014 Apr; 82():1-6. PubMed ID: 24378780
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and in vitro biological evaluation of novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing a thiosemicarbazide moiety.
Geng PF; Liu XQ; Zhao TQ; Wang CC; Li ZH; Zhang J; Wei HM; Hu B; Ma LY; Liu HM
Eur J Med Chem; 2018 Feb; 146():147-156. PubMed ID: 29407946
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and preliminary biological evaluation of 5,8-dihydropteridine-6,7-diones that induce apoptosis and suppress cell migration.
Geng PF; Wang CC; Li ZH; Hu XN; Zhao TQ; Fu DJ; Zhao B; Yu B; Liu HM
Eur J Med Chem; 2018 Jan; 143():1959-1967. PubMed ID: 29133051
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel 7-amino-[1,2,4]triazolo[4,3-f]pteridinone, and 7-aminotetrazolo[1,5-f]pteridinone derivative as potent antitumor agents.
Hou Y; Zhu L; Li Z; Shen Q; Xu Q; Li W; Liu Y; Gong P
Eur J Med Chem; 2019 Feb; 163():690-709. PubMed ID: 30572179
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel 4-(2-fluorophenoxy)quinoline derivatives bearing 4-oxo-1,4-dihydrocinnoline-3-carboxamide moiety as c-Met kinase inhibitors.
Li S; Zhao Y; Wang K; Gao Y; Han J; Cui B; Gong P
Bioorg Med Chem; 2013 Jun; 21(11):2843-55. PubMed ID: 23628470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
